Tissue Engineering and Regenerative Medicine Laboratory, Department of Biomedical Engineering, İzmir Katip Çelebi University, İzmir, 35620, Turkey.
Soft Matter. 2021 Jul 14;17(27):6616-6626. doi: 10.1039/d1sm00680k.
Fabrication of vascularized tissue constructs plays an integral role in creating clinically relevant tissues. Scaffold materials should be sufficiently vascularized to mimic functional and complex native tissues. Herein, we report the development of bioactive and biomimetic self-assembled peptide (SAP) hydrogels that allow the rapid formation of a vascular structure in vitro. The KLDLKLDLKLDL (KLD peptide) SAP was functionalized with laminin derived peptides IKVAV (V1) and YIGSR (V2) through direct coupling to mimic the natural extracellular matrix (ECM) and human umbilical endothelial cells (HUVECs) and mesenchymal stem cells (MSCs) cultured in 0.5% and 1% SAP hydrogels organized into vascularized structures. Atomic force microscopy (AFM) and scanning electron microscopy (SEM) images proved the molecular integration of the nanofibrous structure in SAP hydrogels. The stability of SAP hydrogels was confirmed by rheological and degradation measurements. Bioactive peptide scaffolds enhanced significantly HUVEC/hMSC proliferation depicted by MTT analysis compared to KLD. Furthermore, the real time quantitative polymerase chain reaction (rt-PCR) was performed to analyse vascular gene expressions such as platelet/endothelial cell adhesion molecule-1 (PECAM-1), von Willebrand factor (vWF), and vascular endothelial cadherin (VE-cadherin). The results indicated that the KLD-V2 hydrogel significantly induced vasculogenesis in hMSC/HUVEC co-culture compared to KLD-V1, Biogelx and KLD because YIGSR in KLD-V2 promoted cell population and ECM secretion by the interaction with cells and increased vasculogenesis. Overall, the designed SAP hydrogel represents an effective scaffold for vascularization of tissue constructs with useful tissue engineering applications.
构建血管化组织对于创造具有临床相关性的组织起着不可或缺的作用。支架材料应具有足够的血管化程度,以模拟功能性和复杂的天然组织。在此,我们报告了生物活性和仿生自组装肽(SAP)水凝胶的开发,该水凝胶允许在体外快速形成血管结构。KLDLKLDLKLDL(KLD 肽)SAP 通过直接偶联功能化了层粘连蛋白衍生肽 IKVAV(V1)和 YIGSR(V2),以模拟天然细胞外基质(ECM)和在 0.5%和 1%SAP 水凝胶中培养的人脐静脉内皮细胞(HUVECs)和间充质干细胞(MSCs)组织成血管化结构。原子力显微镜(AFM)和扫描电子显微镜(SEM)图像证明了 SAP 水凝胶中纳米纤维结构的分子整合。通过流变学和降解测量证实了 SAP 水凝胶的稳定性。与 KLD 相比,生物活性肽支架显著增强了 HUVEC/MSC 的增殖,MTT 分析结果表明。此外,还进行了实时定量聚合酶链反应(rt-PCR)以分析血管生成基因的表达,如血小板/内皮细胞黏附分子-1(PECAM-1)、血管性血友病因子(vWF)和血管内皮钙黏蛋白(VE-cadherin)。结果表明,与 KLD-V1、Biogelx 和 KLD 相比,KLD-V2 水凝胶在 hMSC/HUVEC 共培养中显著诱导血管生成,因为 KLD-V2 中的 YIGSR 通过与细胞相互作用促进细胞群体和 ECM 分泌,并增加血管生成。总体而言,设计的 SAP 水凝胶代表了组织构建血管化的有效支架,具有有用的组织工程应用。